
DETECT— Engaging Patients, Caregivers, and Multidisciplinary Providers in the Shared Goal of Facilitating an Earlier Alzheimer’s Disease Diagnosis and Optimizing the Use of Anti-Amyloid Therapies
Treatment Topic: Optimizing the Use of Anti-Amyloid Therapy for Early Asymptomatic AD
This case-based educational enduring activity is designed to help Alzheimer’s disease and dementia healthcare providers optimize the use of anti-amyloid therapy for early Alzheimer’s disease. Through interactive case-based learning, our faculty will assist learners in developing strategies to improve multidisciplinary and clinician/patient communication skills to facilitate the best possible treatment outcomes.
RELEASED DATE: August 29, 2025
EXPIRATION DATE: August 29, 2026

DETECT— Engaging Patients, Caregivers, and Multidisciplinary Providers in the Shared Goal of Facilitating an Earlier Alzheimer’s Disease Diagnosis and Optimizing the Use of Anti-Amyloid Therapies
Facilitating an Earlier Alzheimer’s Disease Diagnosis
This case-based educational activity is designed to help Alzheimer’s disease and dementia providers diagnose AD earlier in the disease course through comprehensive history and physical, validated cognitive assessments, neuroimaging, and referral, when appropriate. Through interactive case-based learning, our faculty will assist learners in developing strategies to improve multidisciplinary care and clinician/patient communication to facilitate the best possible treatment outcomes.
RELEASED DATE: August 29, 2025
EXPIRATION DATE: August 29, 2026

DETECT— Navigating a New Era in Alzheimer’s Disease: Integrating Disease-Modifying Therapies into Clinical Practice
This four-episode podcast is designed to identify and analyze the educational needs and practice gaps that exist among healthcare practitioners who are involved in the diagnosis and management of patients with Alzheimer’s disease. This program will educate participants on providing a timely diagnosis, referral, and appropriate treatment. We will hear from a primary care physician, a neurologist, a geriatrician, and a geriatric psychiatrist on the importance of multidisciplinary care and shared decisions in the diagnosis and treatment of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD).
RELEASED DATE: April 25, 2025
EXPIRATION DATE: May 16, 2026

DETECT— Navigating a New Era in Alzheimer’s Disease: Integrating Disease-Modifying Therapies into Clinical Practice
In this enduring grand rounds program, we will provide instruction on screening, diagnosing, and staging of mild cognitive impairment and Alzheimer's disease. The lecture and case-based scenarios will educate on the appropriate use of disease-modifying therapy, assessing and managing adverse events associated with these therapies, and implementing tools to solve issues with access to therapy. Finally, the faculty will discuss shared decision making and multidisciplinary teams as essential elements for successful care of these patients.
RELEASED DATE: May 15, 2025
EXPIRATION DATE: May 15, 2026

DETECT— Navigating a New Era in Alzheimer’s Disease: Integrating Disease-Modifying Therapies into Clinical Practice
This educational activity is designed to provide participants with important clinical information on screening, diagnosing, and staging mild cognitive impairment and Alzheimer's disease. Through the use of high-quality images and graphics, along with detailed slide-based presentation, our faculty will address clinical practice recommendations informing the use of disease-modifying therapy for Alzheimer's disease, and provide tools on how to best assess and manage potential adverse events associated with these agents. This educational program will help clinicians to apply best practices for shared decision making with patients, including discussion of treatment benefits, risks, and therapy expectations.
RELEASED DATE: May 20, 2025
EXPIRATION DATE: May 20, 2026

DETECT— Navigating a New Era in Alzheimer’s Disease: Integrating Disease-Modifying Therapies into Clinical Practice
This enduring activity is designed to offer multidisciplinary expert perspectives on the early identification of mild cognitive impairment (MCI) associated with Alzheimer’s disease (AD), appropriate patient referral, as well as treatment individualization for AD, focusing on disease-modifying therapies and their application to patient care. Through expert pearls and interactive case-based discussions, this series will highlight key considerations across both primary and specialty care in order to optimize multidisciplinary collaboration and patient outcomes throughout the care continuum.
RELEASED DATE: June 01, 2025
EXPIRATION DATE: June 01, 2026

DETECT— Navigating a New Era in Alzheimer’s Disease: Integrating Disease-Modifying Therapies into Clinical Practice
Topic 1: Early Detection of MCI Due to AD
This case-based educational activity is designed to enable providers who manage patients with Alzheimer's disease (AD) to more effectively diagnose mild cognitive impairment (MCI) due to AD. Expert faculty will review updated criteria for screening, diagnosis, and staging; outline best practices for patient evaluation, including medical history and cognitive and diagnostic screening tools; and provide guidance on when to refer patients to specialists. Employing an interactive case-based learning platform, our faculty will assist learners with developing strategies to improve multidisciplinary and clinician/patient communication for shared decision making.
RELEASED DATE: June 30, 2025
EXPIRATION DATE: June 30, 2026

DETECT— Navigating a New Era in Alzheimer’s Disease: Integrating Disease-Modifying Therapies into Clinical Practice
This program has been developed to educate health care practitioners who care for patients with Alzheimer’s disease on the importance of early diagnosis of mild cognitive impairment (MCI) due to Alzheimer’s disease, timely specialist referral, and effective treatment and monitoring of patients receiving anti-amyloid therapies. It highlights the importance of a multidisciplinary, shared decision-making approach to optimize care management. This Day in the Life docuseries provides unique insights into the patient’s journey from diagnosis to treatment and the physician’s perspective on the clinical strategies for managing disease symptoms.
RELEASED DATE: July 25, 2025
EXPIRATION DATE: July 25, 2026

DETECT— Navigating a New Era in Alzheimer’s Disease: Integrating Disease-Modifying Therapies into Clinical Practice
Thursday, November 06, 2025
7:00PM – 8:30PM ET
Please note this Clinical Conversation program is 7:00PM Eastern, 6:00PM Central, 5:00PM Mountain and 4:00PM Pacific.

DETECT— Navigating a New Era in Alzheimer’s Disease: Integrating Disease-Modifying Therapies into Clinical Practice
Wednesday, November 12, 2025
12:00PM – 1:30PM ET
Please note this Clinical Conversation program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.















































